Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abandon, accuracy, aid, Albany, Alpharma, altogether, amenable, amplification, Analyst, antidepressant, Antitrust, architecturally, aRNA, arrest, assignee, attendance, attended, Austria, automatic, automatically, award, awarded, bad, Bank, banking, Bay, bear, BI, bioscience, biotech, Boehringer, breadth, Bringing, brown, Cambrex, carcinogenicity, cardiology, cardiovascular, career, cautionary, CEO, certify, certifying, CFA, cinacalcet, circumstance, clearance, CNS, complicated, confusingly, contrary, Coping, correct, corrected, corrective, correlated, court, CPL, CV, Cygne, defending, dehydration, denominated, deterioration, Developmental, Diagnostic, directorship, dissolution, diverted, doubtful, draft, drop, eighteen, Einstein, electronically, Endocrine, Engineering, entirety, Enzon, exact, expedite, expressly, faculty, fast, fellow, female, femoral, filer, fill, fluid, forfeiture, formula, fraud, freedom, fullest, furnish, furnished, George, Gerard, Glaxo, global, GmbH, guarantee, guarantor, Guilford, Hamilton, harbor, HCl, headache, heavily, Hemosol, Histological, hyperparathyriodism, implied, Indirect, individual, inflammation, Ingelheim, injector, inserted, Internet, interpretation, Joseph, Justice, Kaufmann, Klein, Layton, LBS, LC, learning, Lederle, light, LLC, Lorna, malabsorption, malnutrition, Manchester, mandatory, manifested, ManuPharm, Maupin, MDS, Medeva, medium, member, membership, memory, methodology, Michel, Microbiology, misleading, monitizing, monthly, moral, morgan, morphology, moving, multidisciplinary, multitude, narrow, Neurobiology, Neuroscience, neurotransmitter, Newton, NMDA, nominee, noncontingent, Ohio, omit, optionee, overcome, owner, PaineWebber, Parrish, Parsipanny, passed, PEG, Pennsylvania, perception, permitted, permitting, Pharma, Pharmacy, physician, plagued, powder, precipitation, premium, presumption, procurement, rata, ready, reclassified, reconstituted, refined, refrigeration, regularly, relationship, relocation, remeasured, reoccur, Reorganization, replicate, resection, residence, Ribapharm, Richmond, Rochester, Roerig, Rorer, Rowe, Rygiel, salary, Saskatchewan, SCA, sedation, sound, spasticity, specialty, Spectral, spent, spouse, St, stability, stable, stand, Stanford, startup, Stephen, strictly, subordinated, survey, Task, Taylor, telephone, terminology, terraparitide, threat, Torstar, track, Transnational, twenty, unanimously, understanding, unexercised, unfeasible, unfunded, uniform, unlawful, unmet, untrue, urgent, vacuolization, variability, variable, vendor, VIE, VivoQuest, wall, website, Wharton, whereunder, Winder, winding, withhold, York
Removed:
allocation, ALX, assigned, assumed, Attorney, binding, canceled, caption, cautioned, constituted, converted, deny, dose, estimating, expand, Expiring, facility, fed, formal, GATX, inefficient, intensely, Intent, intravenously, investing, jurisdiction, Kellogg, KPMG, level, LLP, marked, merrell, neurological, nonrecurring, Northwestern, obligate, occurred, permanently, phosphate, preclude, presently, pursuit, recovery, robert, SIDDCO, speak, Supplemental, technique, Treasurer, undue
Filing tables
Filing exhibits
- 10-K Annual report
- 3.2 Certificate of Adoption
- 10.1 1987 Stock Option Plan
- 10.2 1994 Equity Incentive Plan
- 10.3 1994 Non-employee Directors' Stock Option Plan
- 10.4 1994 Employee Stock Purchase Plan
- 10.5 1998 Stock Option Plan
- 10.7 Severance Pay Plan
- 10.8 Amendment Agreement to Amend the 11/26/97
- 10.8 Amendment Agreement
- 10.8 Amendment Agreement to Amend the 01/24/00
- 10.9 Letter Agreement for Patent Agreement 02/19/93
- 10.9 1999 Patent Agreement Amendment
- 10.12 First Amendment to Lease - Expansion
- 10.12 Second Amendment to Lease - Expansion
- 10.12 Third Amendment to Lease - Expansion
- 10.12 Fourth Amendment to Lease
- 10.12 Fifth Amendment to Lease
- 21.1 List of Subsidiaries
- 23.1 Consent of Independent Auditors
- 99.1 Certification Hunter Jackson
- 99.2 Certification Morgan R. Brown
NPSP similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Auditors
The Board of Directors and Stockholders
NPS Pharmaceuticals, Inc.
We consent to incorporation by reference in the registration statements (Nos. 33-79622, 333-17521, and 333-94269) on Forms S-8, and (Nos. 333-41758 and 333-76532) on Forms S-3 of NPS Pharmaceuticals, Inc. of our report dated January 30, 2003, except as to note 14 which is as of February 19, 2003, relating to the consolidated balance sheets of NPS Pharmaceuticals, Inc. and subsidiaries (a development stage enterprise) as of December 31, 2002 and 2001, and the related consolidated statements of operations, stockholders’ equity and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2002, and for the period from October 22, 1986 (inception) to December 31, 2002, which report appears in the December 31, 2002, annual report on Form 10-K of NPS Pharmaceuticals, Inc.
Our report refers to a change in the method of amortizing goodwill and intangible assets in 2002 and a change in the method of recognizing revenue on nonrefundable licensing fees in 2000.
/s/ KPMG LLP | |
Salt Lake City, Utah | |
March 19, 2003 |